Date published: 2026-5-19

1-800-457-3801

SCBT Portrait Logo
Seach Input

Ipsapirone (CAS 95847-70-4)

0.0(0)
Write a reviewAsk a question

Alternate Names:
TVX Q 7821
Application:
Ipsapirone is a selective SR-1A agonist
CAS Number:
95847-70-4
Purity:
≥99%
Molecular Weight:
401.48
Molecular Formula:
C19H23N5O3S
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Ipsapirone, also known as TVX Q 7821, is a SR-1A agonist and has been found to selectively bind to SR-1 receptors. Only at high doses, this compound shows the ability to inhibit 1-adrenergic and SR-2 function. Exposure of ethanol treated rhombencephalic neurons to Ipsapirone has been reported to prevent ethanol-associated apoptosis of the cells and also activate the PI3K/Akt pro-survival pathway. Additionally, the expression of NF-kappaB dependent anti-apoptotic genes as well as Bcl-XL, catalase, and XIAP expression were augmented in the rhombencephalic neurons.


Ipsapirone (CAS 95847-70-4) References

  1. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635.  |  de Boer, SF., et al. 1999. J Pharmacol Exp Ther. 288: 1125-33. PMID: 10027850
  2. Neuroendocrine and behavioral responses during conditioned active and passive behavior in the defensive burying/probe avoidance paradigm: effects of ipsapirone.  |  Korte, SM., et al. 1992. Physiol Behav. 52: 355-61. PMID: 1355919
  3. Alteration of 5-HT1A receptor binding sites following chronic treatment with ipsapirone measured by quantitative autoradiography.  |  Fanelli, RJ. and McMonagle-Strucko, K. 1992. Synapse. 12: 75-81. PMID: 1357765
  4. Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies.  |  Schechter, LE., et al. 1990. J Pharmacol Exp Ther. 255: 1335-47. PMID: 1702155
  5. Effects of ethanol and ipsapirone on the expression of genes encoding anti-apoptotic proteins and an antioxidant enzyme in ethanol-treated neurons.  |  Lee, JH., et al. 2009. Brain Res. 1249: 54-60. PMID: 18992726
  6. Response of cerebellar Purkinje cells to serotonin and the 5-HT1A agonists 8-OH-DPAT and ipsapirone in vitro.  |  Darrow, EJ., et al. 1990. Eur J Pharmacol. 175: 145-53. PMID: 1968842
  7. Evidence that the 5-HT1A receptor agonists buspirone and ipsapirone activate adrenaline release in the conscious rat.  |  Chaouloff, F., et al. 1990. Eur J Pharmacol. 177: 107-10. PMID: 2340854
  8. Alterations of central serotonin and dopamine turnover in rats treated with ipsapirone and other 5-hydroxytryptamine1A agonists with potential anxiolytic properties.  |  Hamon, M., et al. 1988. J Pharmacol Exp Ther. 246: 745-52. PMID: 2457083
  9. Central action of ipsapirone, a new anxiolytic drug, on serotoninergic, noradrenergic and dopaminergic functions.  |  Maj, J., et al. 1987. J Neural Transm. 70: 1-17. PMID: 2889795
  10. Binding of the putative anxiolytic TVX Q 7821 to hippocampal 5-hydroxytryptamine (5-HT) recognition sites.  |  Glaser, T. and Traber, J. 1985. Naunyn Schmiedebergs Arch Pharmacol. 329: 211-5. PMID: 3160954
  11. Brain serotonin receptors as a target for the putative anxiolytic TVX Q 7821.  |  Traber, J., et al. 1984. Brain Res Bull. 12: 741-4. PMID: 6541079
  12. Anxiolytic effect of the 5-HT1A compounds 8-hydroxy-2-(di-n-propylamino) tetralin and ipsapirone in the social interaction paradigm: evidence of a presynaptic action.  |  Picazo, O., et al. 1995. Brain Res Bull. 37: 169-75. PMID: 7606493
  13. Neurotrophic effects of ipsapirone and other 5-HT1A receptor agonists on septal cholinergic neurons in culture.  |  Riad, M., et al. 1994. Brain Res Dev Brain Res. 82: 245-58. PMID: 7842512
  14. Neuronal circuits involved in the anxiolytic effects of the 5-HT1A receptor agonists 8-OH-DPAT ipsapirone and buspirone in the rat.  |  Schreiber, R. and De Vry, J. 1993. Eur J Pharmacol. 249: 341-51. PMID: 7904566
  15. Effect of acute and repeated versus sustained administration of the 5-HT1A receptor agonist ipsapirone: electrophysiological studies in the rat hippocampus and dorsal raphe.  |  Dong, J., et al. 1997. Naunyn Schmiedebergs Arch Pharmacol. 356: 303-11. PMID: 9303566

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Ipsapirone, 10 mg

sc-203607
10 mg
$129.00

Ipsapirone, 50 mg

sc-203607A
50 mg
$525.00